Mylan and its subsidiary, Mylan Pharmaceuticals, have signed a settlement agreement with Pfizer, Pharmacia & Upjohn Company and Pfizer Health related to Detrol LA patent litigation. The litigation is related to Mylan Pharmaceuticals' ...
TTY Biopharm Co.,Ltd.,a major pharmaceutical maker in Taiwan,recently inaugurated a drug factory in Suzhou,Jiangsu Province of China,operated by TTY`s Chinese subsidiary TOT Biopharm Co.,Ltd. At a cost of about US$100 million,the factory ...
Tags: TTY Biopharm, drug factory, anti-cancer drug injections, Suzhou
ProMetic Life Sciences and NantPharma have together formed an affiliate company, NantPro BioSciences, to develop and commercialize a plasma-derived biopharmaceutical product for the US market. The new US based company has entered into ...
Tags: affiliate company, plasma-derived biopharmaceutical product
The US Food and Drug Administration (FDA) has cleared Hope Pharmaceuticals' Sodium Nitrite Injection for use with sodium thiosulfate for the treatment of cyanide poisoning. Sodium Nitrite Injection (NDC 60267-311-10) is packaged in a 10mL ...
Tags: Sodium Nitrite Injection, sodium thiosulfate, cyanide poisoning
Novartis has commenced shipment of Fluvirin influenza vaccine for the 2012-2013 influenza season, in the US. Novartis plans to ship more than 30 million doses of the Fluvirin vaccine which has been reformulated to include two new ...
Tags: Novartis, fluvirin influenza seasonal vaccine, seasonal influenza
Bristol-Myers Squibb, a biopharmaceutical company, has terminated the development of BMS-986094, an investigational NS5B nucleotide for the treatment of hepatitis C. Based on an ongoing assessment of patients in a Phase II study that the ...
Tags: BMS-986094, Bristol-Myers, hepatitis C, NS5B nucleotide
Sanofi vaccines division, Sanofi Pasteur, has begun shipping of the first lots of Fluzone vaccine to US health care providers following Food and Drug Administration (FDA) licensure of the 2012-2013 formulation. The shipment represents ...
Tags: Influenza Virus, health care, Food and Drug
Mobius Therapeutics, an ophthalmic company, has begun commercial shipments of Mitosol (mitomycin for solution) kit for ophthalmic use. Mitosol will provide a new system for delivering a precise dose of its active ingredient, mitomycin-c, ...
The US Food and Drug Administration (FDA) has suspended the operations of Sunland, a producer of nuts, and nut and seed spreads, over food safety concerns. Sunland which operates a processing facility in New Mexico, has been linked to an ...
Tags: food safety, Agriculture
Onyx Pharmaceuticals, a licensee of Ligand Pharmaceuticals, has gained FDA approval for Kyprolis (carfilzomib) for injection. Kyprolis is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have ...
Tags: Onyx Pharmaceuticals, Ligand Pharmaceuticals, Kyprolis
Laser vendors stay cautiously optimistic 24 Oct 2012 Longbow Research finds industrial demand staying positive and fiber lasers gaining market share in the third quarter of 2012. Big business: QCW sources from IPG The regular quarterly ...
Tags: IPG PhotonicsLongbow Research, fiber lasers, IPG, IPG Photonics
Forest Laboratories and Adamas Pharmaceuticals have collaborated for the development of a fixed dosed combination (FDC) of Namenda XR and donepezil HCl for Alzheimer's dementia in the US. The company expects to launch the FDC that will be ...
ViaCyte has received a $10.1m strategic partnership award from the California Institute for Regenerative Medicine (CIRM) to develop VC-01, which is a regenerative medicine, consisting of pancreatic beta cell progenitors in a durable ...
Tags: ViaCyte, Diabetes Therapy Development, CIRM
Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application for Olanzapine tablets USP, 2.5mg, 5mg, 7.5mg, 10mg, 15mg, and 20mg. The company begins the shipment of the product, which is the generic equivalent ...
Tags: Generic Zyprexa Tablets, Mylan Pharmaceuticals, new drug
Pfizer and Protalix BioTherapeutics have announced FDA approval of Elelyso (taliglucerase alfa) for injection to treat type 1 Gaucher disease. Elelyso, derived from ProCellEx, is an enzyme replacement therapy (ERT) for the long-term ...
Tags: Protalix/Pfizer Gaucher Drug, Pfizer and Protalix BioTherapeutics